Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 47, 3130-3135, June 15, 1987]
© 1987 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jamieson, G. P.
Right arrow Articles by Wiley, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jamieson, G. P.
Right arrow Articles by Wiley, J. S.

Degradation of 1-ß-D-Arabinofuranosylcytosine 5'-Triphosphate in Human Leukemic Myeloblasts and Lymphoblasts1

G. P. Jamieson, L. R. Finch, M. Snook and J. S. Wiley2

Department of Haematology [G. P. J., M. S., J. S. W.], Austin Hospital, Heidelberg, Melbourne, 3084, and Russell Grimwade School of Biochemistry [L. R. F.], University of Melbourne, Parkville, Melbourne, 3052, Australia

The intracellular half-life for retention of the active triphosphate metabolite 1-ß-D-arabinofuransylcytosine 5'-triphosphate (araCTP) of 1-ß-D-arabinofuranosylcytosine was measured in vitro in blast cells from patients with acute myeloblastic leukemia, acute lymphoblastic leukemia, and T-cell lymphoblastic lymphoma. araCTP accumulation from 1 µM 1-ß-D-arabinofuranosylcytosine in leukemic blast cells was closely correlated with the nucleoside transport capacity as measured by equilibrium binding of [3H]nitrobenzylthioinosine. The half-life of araCTP retention was related to araCTP accumulation only when the level of araCTP was expressed as a percentage of total intracellular 1-ß-D-arabinofuranosylcytosine metabolites. Accumulation of 1-ß-D-arabinofuranosyluracil 5'-monophosphate was inversely related to the half-life of araCTP retention and directly related to dCMP deaminase activity in cell free extracts. No conversion of 1-ß-D-arabinofuranosyluracil to 1-ß-D-arabinofuranosyluracil 5'-monophosphate was detectable in intact cells. The end product of araCTP degradation was 1-ß-D-arabinofuranosyluracil and it is proposed that conversion of 1-ß-D-arabinofuranosylcytosine 5'-monophosphate to 1-ß-D-arabinofuranosyluracil 5'-monophosphate is a step in the degradative pathway of araCTP. However, it is the cells' nucleoside transport capacity which primarily determines the level of intracellular araCTP accumulation.

1 This research was carried out during the tenure of a grant from the Anti Cancer Council of Victoria.

2 To whom requests for reprints should be addressed.

Received 11/25/85. Revised 2/ 4/87. Accepted 3/13/87.




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
J.-Y. Liou, P. Krishnan, C.-C. Hsieh, G. E. Dutschman, and Y.-c. Cheng
Assessment of the Effect of Phosphorylated Metabolites of Anti-Human Immunodeficiency Virus and Anti-Hepatitis B Virus Pyrimidine Analogs on the Behavior of Human Deoxycytidylate Deaminase
Mol. Pharmacol., January 1, 2003; 63(1): 105 - 110.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1987 by the American Association for Cancer Research.